Milibact 250mg/125mg Injection
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Milibact 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats various bacterial infections by inhibiting microbial proliferation. Administration must be solely under medical guidance. Consistent adherence to the prescribed dosage schedule is crucial; premature cessation can compromise treatment efficacy. Complete the full course, even with symptom improvement. Typical mild side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening symptoms or allergic reactions (rash, itching, swelling, dyspnea) immediately. Inform your physician of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, avoid operation of vehicles if drowsiness or dizziness occurs. Sufficient rest, nutrition, and hydration contribute to faster recovery. Laboratory monitoring may be implemented to assess treatment response.
Primary Ingredients of Milibact 250mg/125mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Milibact 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Milibact 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
Common Side effects of Milibact 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Milibact 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Milibact 250mg/125mg Injection works:
Ceftriaxone/Sulbactam 250 mg/125 mg Injection (Milibact) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism of action disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Milibact 250 mg/125 mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Milibact 250 mg/125 mg is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingCAUTION
The administration of Milibact 250 mg/125 mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Milibact 250 mg/125 mg Injection can lead to reduced awareness, visual impairment, drowsiness, and dizziness. Operation of a vehicle should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Milibact 250 mg/125 mg Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Patients with severe hepatic impairment should receive Milibact 250 mg/125 mg Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dosage alteration for Milibact 250 mg/125 mg Injection is unnecessary in individuals with mild or moderate liver dysfunction.
What if you forget to take Milibact 250mg/125mg Injection :
Should you forget a scheduled dose of Milibact 250 mg/125 mg Injection, seek medical advice.
Facts to Know About Milibact 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infectives |
3,018 People bought this recently